First Time Loading...

Bellerophon Therapeutics Inc
NASDAQ:BLPH

Watchlist Manager
Bellerophon Therapeutics Inc Logo
Bellerophon Therapeutics Inc
NASDAQ:BLPH
Watchlist
Price: 0.0625 USD 21.83% Market Closed
Updated: May 3, 2024

Bellerophon Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bellerophon Therapeutics Inc
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bellerophon Therapeutics Inc
NASDAQ:BLPH
Revenue
$5.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.7B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Revenue
$21B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

See Also

What is Bellerophon Therapeutics Inc's Revenue?
Revenue
5.6m USD

Based on the financial report for Jun 30, 2023, Bellerophon Therapeutics Inc's Revenue amounts to 5.6m USD.